Metabolic Dysfunction Associated SteatohepatitisPhase 3NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Phase 3 study testing Survodutide in people with Metabolic Dysfunction Associated Steatohepatitis, run by Boehringer Ingelheim at 447 sites in 37 countries.
Trial summary
This study is open to adults who are at least 18 years old and have: A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or A confirmed liver disease called metabolic-associated steatohepatitis (MASH) BMI of 27 kg/m2 or more or 25 kg/m2 or more if the participant is Asian. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Metabolic Dysfunction Associated Steatohepatitis
- What is being tested?
- Survodutide
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 1,590 participants
- Where
- 447 sitesin 37 countries
- Study dates
- 12 Nov 2024to 5 Jun 2029
- Phase
- Phase 3
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male or female adults ≥18 years of age at the time of screening, and at least the legal age of consent in countries where it is >18 years
- Body mass index (BMI) ≥27 kg/m2(≥25 kg/m2 for Asian trial participants)
- Compensated metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.
- Magnetic resonance imaging proton density fat fraction (MRI-PDFF) fat fraction ≥5% or FibroScan® with controlled attenuation parameter (CAP) ≥288 dB/m, obtained during the screening period or a historic MRI-PDFF ≤12 weeks prior to randomisation (except for patients with 'cryptogenic cirrhosis' where MRI-PDFF <5% or FibroScan® with CAP <288 dB/m is allowed). This inclusion criterion does not apply for participants with a recent (≤12 months prior to randomisation) liver biopsy showing steatosis/steatohepatitis.
- Further inclusion criteria apply.
Who cannot join
- Current or history (<5 years) of significant alcohol consumption, defined as an average of >140 g/week in female patients and >210 g/week in male patients, for a period of >3 consecutive months, or an inability to reliably quantify alcohol consumption based upon judgment of the investigator.
- Model of end-stage liver Disease (MELD) score >12 due to liver disease
- History or current (i.e. at screening) hepatic decompensation event of any of the following but not limited to:
- Portal hypertension-related upper gastrointestinal (GI) bleeding
- Ascites
- Hepatic encephalopathy (HE) ≥Grade 1 according to the West Haven criteria
Show all 20Show fewer
- Any of the following lab test result at screening
- Albumin below <3.5 g/dL (<35.0 g/L)
- International normalised ratio (INR) >1.3 unless due to therapeutic anticoagulants
- Total bilirubin (TBL) >1.2x upper limit of normal (ULN) NOTE: Trial participants with Gilbert Syndrome are eligible with a TBL >1.2x ULN if reticulocyte count is within normal limits, haemoglobin is within normal limits unless due to chronic anaemia and unrelated to haemolysis, and direct bilirubin is <20% of TBL.
- Alkaline phosphatase >1.5x ULN
- PLT <100,000/µL (<100 GI/L)
- History or evidence of other chronic liver diseases, such as primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis or overlap syndrome, Wilson's disease, alpha-1-antitrypsin deficiency, or genetic haemochromatosis
- Hepatitis B positive (defined as positive hepatitis B surface antigen (HBsAg)) or history of chronic HBV infection
- Hepatitis C positive (defined as positive hepatitis C virus (HCV) antibody and a positive HCV ribonucleic acid (RNA))
- Serum aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) >5x ULN
- Evidence of alcoholic liver disease, or drug-induced liver disease, as defined on the basis of typical exposure and history
- History of liver transplantation or listed for liver transplantation
- History of transjugular intrahepatic portosystemic shunt (TIPS) or other radiological/surgical procedure for portal hypertension treatment
- Further exclusion criteria apply
Trial locations and contacts
447 sites in 37 countries. Contact the study team or a site near you to ask about taking part.
447 sites in 37 countries
United States126 sites, 126 recruiting
- Recruiting
Texas Clinical Research Institute, LLC
Arlington, Texas, 76012
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Piedmont Hospital
Atlanta, Georgia, 30309
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
IMA Clinical Research Austin
Austin, Texas, 78745
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
American Research Corporation - Austin
Austin, Texas, 78757
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Pinnacle Clinical Research - Austin
Austin, Texas, 78757
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research, Austin
Austin, Texas, 78759
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Delta Research Partners, LLC
Bastrop, Louisiana, 71220
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Pinnacle Clinical Research, LLC
Bellaire, Texas, 77401
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Synergy Healthcare
Bradenton, Florida, 34209
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Synergy Healthcare of Tampa
Brandon, Florida, 33511
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Connecticut Gastroenterology Clinical Research Foundation
Bristol, Connecticut, 06010
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, 11215
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Access research Institute
Brooksville, Florida, 34613
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
South Texas Research Institute - Brownsville
Brownsville, Texas, 78520
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Hope Clinical Research
Canoga Park, California, 91303
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ClinSearch, LLC
Chattanooga, Tennessee, 37421
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research-Chula Vista
Chula Vista, California, 91911
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Innovative Clinical Research
Clarksville, Tennessee, 37040
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Clinical Research Institute of Michigan, LLC
Clinton Township, Michigan, 48038
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Future Innovative Treatments
Colorado Springs, Colorado, 80907
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ObjectiveHealth-GI Associates Research
Columbia, Missouri, 65201
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ObjectiveHealth-Columbia Digestive Health Research
Columbia, South Carolina, 29204
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Hi Tech and Global Research, LLC
Coral Gables, Florida, 33134
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Southern California Research Center
Coronado, California, 92118
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Cenara Clinical Research
Cutler Bay, Florida, 33189
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Dallas Research Institute
Dallas, Texas, 75150
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Zenos Clinical Research
Dallas, Texas, 75230
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
GI Alliance Research - Dallas
Dallas, Texas, 75246
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Soma Clinical Trials
Denison, Texas, 75020
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
South Denver Gastroenterology PC
Englewood, Colorado, 80113
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Coastal Research Institute, LLC
Fayetteville, North Carolina, 28304
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
US Digestive Health
Flourtown, Pennsylvania, 19031
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Covenant Metabolic Specialists, LLC - Fort Myers
Fort Myers, Florida, 33912
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ARK Clinical Research
Fountain Valley, California, 92708
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
EmVenio Research Center at Prime Healthcare - Farmers Branch
Garden City, Texas, 48135
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
DHAT Reseach Institute
Garland, Texas, 75044
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Pinnacle Clinical Research, LLC
Georgetown, Texas, 78626
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Carolina Researche
Greenville, North Carolina, 27834
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ASHA Clinical Research - Munster, LLC
Hammond, Indiana, 46324
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Neoclinical Research
Hialeah, Florida, 33016
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Evolution Clinical Trials
Hialeah Gardens, Florida, 33016
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Global Research Associates
Homestead, Florida, 33030
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Ben Taub General Hospital
Houston, Texas, 77030-1608
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Biopharma Informatic, Inc. Research Center
Houston, Texas, 77084
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Research Physicians Network
Houston, Texas, 77089
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research-Huntington Park
Huntington Park, California, 90255
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
310 Clinical Research
Inglewood, California, 90301
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Kansas City Research Institute
Kansas City, Missouri, 64131
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research, San Diego
La Mesa, California, 91942
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Lake Center for Clinical Research
Lady Lake, Florida, 32159
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Om Research, LLC
Lancaster, California, 93534
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
US Digestive Health
Lancaster, Pennsylvania, 17601
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Jubilee Clinical Research, Inc
Las Vegas, Nevada, 89106
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Excel Clinical Research
Las Vegas, Nevada, 89109
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Clinical Research of South Nevada
Las Vegas, Nevada, 89121
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Basil Clinical
Laurelton, New York, 11413
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Epic Clinical Research
Lewisville, Texas, 75057
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Gastroenterology Associates of Central Georgia
Macon, Georgia, 31201
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
GI Alliance Research - Mansfield
Mansfield, Texas, 76063
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Tandem Clinical Research
Marrero, Louisiana, 70072
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Biopharma Informatic LLC
McAllen, Texas, 78503
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Centex Studies, Inc.
McAllen, Texas, 78504
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Great Lakes Gastroenterology
Mentor, Ohio, 44060
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Research Associates of South Florida, LLC
Miami, Florida, 33134
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Optimus U Corporation-Miami-69452
Miami, Florida, 33135
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Schiff Center Liver Diseases
Miami, Florida, 33136
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
BioMed Research & Medical Center
Miami, Florida, 33156
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
MplusM - Century Research
Miami, Florida, 33173
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ECIR Miami Holdings LLC dba IMIC
Miami, Florida, 33176
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Entrust Clinical Research
Miami, Florida, 33176
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Floridian Clinical Research
Miami Lakes, Florida, 33016
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
MNGI Digestive Health, PA
Minneapolis, Minnesota, 55413
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Catalina Research Institute, LLC
Montclair, California, 91763
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, 37232
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Advanced Research Institute
New Port Richey, Florida, 34653
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Not yet recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, 10029
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
University of Nebraska Medical Center
Omaha, Nebraska, 68198
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Clinnova Research Solutions
Orange, California, 92868
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Charter Research
Orlando, Florida, 32803
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
OMEGA Research Group
Orlando, Florida, 32808
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Endoscopic Research, Inc
Orlando, Florida, 32828
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Fomat Medical Research
Oxnard, California, 93030
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Innovation Medical Research Center
Palmetto Bay, Florida, 33157
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
MplusM - Best Choice Medical and Research Service
Pembroke Pines, Florida, 33024
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
The Institute for Liver Health II DBA Arizona Clinical Trials
Peoria, Arizona, 85381
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Cadena Care Institute, LLC
Poway, California, 92064
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Ficramed Research Institute
Poway, California, 92064
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
M3 Wake Research, Inc.
Raleigh, North Carolina, 27612
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Inland Empire Clinical Trials, LLC
Rialto, California, 92377
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
GI Select Health Research, LLC
Richmond, Virginia, 23236
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Not yet recruiting
VCU Medical Center West Hospital
Richmond, Virginia, 23298
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
EmVenio Research Center at Prime Healthcare - Riverdale
Riverdale, Georgia, 30274
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Covenant Metabolic Specialist, LLC - Riverview
Riverview, Florida, 33578
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
University of Rochester Medical Center
Rochester, New York, 14642
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
American Research Corporation at the Texas Liver Institute
San Antonio, Texas, 78215
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Brooke Army Medical Center
San Antonio, Texas, 78219
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
HASresearch
San Antonio, Texas, 78240
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Metro Clinical Trials
San Bernardino, California, 92404
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Acclaim Clinical Research
San Diego, California, 92120
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Scottsdale Medical Specialists, Ltd
Scottsdale, Arizona, 85258
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research, Seattle
Seattle, Washington, 98105
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Louisiana Research Center, LLC
Shreveport, Louisiana, 71105
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Digestive Research Alliance of Michiana
South Bend, Indiana, 46635
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research-Spokane-69716
Spokane, Washington, 99218
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ObjectiveHealth-DSI Research - Springboro, LLC
Springboro, Ohio, 45066
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Global Clinical Professionals
St. Petersburg, Florida, 33714
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Palmetto Clinical Research
Summerville, South Carolina, 29485
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
International Center for Research
Tampa, Florida, 33618
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Charter Research
The Villages, Florida, 32162
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Adobe Clinical Research, LLC
Tucson, Arizona, 85712
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Arizona Liver Health - Tucson
Tucson, Arizona, 85712
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Del Sol Research Management, LLC
Tucson, Arizona, 85715
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Options Health Research
Tulsa, Oklahoma, 74104
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Covenant Metabolic Specialists, LLC - University Park
University Park, Florida, 34201
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Velocity Clinical Research, Waco
Waco, Texas, 76710
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Objective Health-Digestive Research of Central Texas
Waco, Texas, 76712
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
IMA Clinical Research-Warren-69742
Warren Township, New Jersey, 07059
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, 50265
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Northshore Gastroenterology Research
Westlake, Ohio, 44145
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
ObjectiveHealth-Digestive Health Research of North Texas
Wichita Falls, Texas, 76301
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Conquest Research
Winter Park, Florida, 32789
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
West Michigan Clinical Research Center
Wyoming, Michigan, 49519
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
US Digestive Health
Wyomissing, Pennsylvania, 19610
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
- Recruiting
Florida Medical Clinic, P.A.
Zephyrhills, Florida, 33542
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Japan55 sites, 55 recruiting
- Recruiting
The University of Tokyo Hospital
Bunkyō City, 113-8655
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Chiba University Hospital
Chiba, 260-8677
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Ehime University Hospital
Ehime, Toon, 791-0295
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Fukuiken Saiseikai Hospital
Fukui-shi, 918-8503
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
National Hospital Organization Kyushu Medical Center
Fukuoka, Fukuoka, 810-8563
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kurume University Hospital
Fukuoka, Kurume, 830-0011
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Gifu Municipal Hospital
Gifu, Gifu, 500-8513
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Ogaki Municipal Hospital
Gifu, Ogaki, 503-8502
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Nagano Municipal Hospital
Hanishina-gun, 381-8551
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Hiroshima University Hospital
Hiroshima, 734-8551
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Japan Community Health Care Organization Hokkaido Hospital
Hokkaido, Sapporo, 062-8618
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Tokyo Medical University Ibaraki Medical Center
Ibaraki, Inashiki-gun, 300-0395
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Tokai University Hospital
Isehara-shi, 259-1193
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kanazawa University Hospital
Ishikawa, Kanazawa, 920-8641
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Shimane University Hospital
Izumo, 693-8501
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kagoshima University Hospital
Kagoshima, 890-8520
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Shin-yurigaoka General Hospital
Kanagawa, Kawasaki, 215-0026
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kagawa University Hospital
Kita-gun, 761-0793
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kobe University Hospital
Kobe, 650-0017
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kumamoto University Hospital
Kumamoto, 860-8556
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Kumamoto Shinto General Hospital
Kumamoto, 862-8655
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
National Hospital Organization Kure Medical Center and Chugoku Cancer Center
Kure, 737-0023
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
University Hospital Kyoto Prefectural University of Medicine
Kyoto, 602-8566
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
University of Miyazaki Hospital
Miyazaki, 889-1692
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Japanese Red Cross Musashino Hospital
Musashino, 186-8610
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Shinshu University Hospital
Nagano, Matsumoto, 390-8621
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Nagasaki Medical Center
Nagasaki, Omura, 856-8562
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Nara Medical University Hospital
Nara, Kashihara, 634-8522
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
International University of Health and Welfare Narita Hospital
Narita, 286-0105
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Niigata University Medical and Dental Hospital
Niigata, 951-8520
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Hyogo College of Medicine Hospital
Nishinomiya, 663-8501
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Oita Cardiovascular Hospital
Ōita, 870-0837
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Okayama University Hospital
Okayama, 700-8558
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Osaka City University Hospital
Osaka, 545-0051
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Saga University Hospital
Saga, 849-8501
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Osaka Rosai Hospital
Sakai, 591-8025
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Seichokai Bell Land General Hospital
Sakai, 599-8247
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Sapporo Kosei General Hospital
Sapporo, 060-0033
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Sendai Tokushukai Hospital
Sendai, 981-3116
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Not yet recruiting
Iwate Medical University Hospital
Shiwa-gun, 028-3695
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Hamamatsu University Hospital
Shizuoka, Hamamatsu, 431-3192
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Juntendo University Shizuoka Hospital
Shizuoka, Izunokuni, 410-2295
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
The University of Osaka Hospital
Suita-shi, 565-0871
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Suita Hospital
Suita-Shi, 564-0013
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
National Hospital Organization Takasaki General Medical Center
Takasaki-shi, 370-0829
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Juntendo University Hospital
Tokyo, 113-8431
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Institute of Science Tokyo Hospital
Tokyo, 113-8519
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Tokyo Medical University Hospital
Tokyo, 160-0023
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Nihon University Itabashi Hospital
Tokyo, 173-8610
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Nippon Medical School Hospital
Tokyo, Bunkyo-ku, 113-8603
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Toranomon Hospital
Tokyo, Minato-ku, 105-8470
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Fujita Health University Hospital
Toyoake-shi, 470-1192
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Mie University Hospital
Tsu, 514-8507
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Wakayama Medical University Hospital
Wakayama, 641-8509
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
- Recruiting
Yokohama City University Hospital
Yokohama, 236-0004
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
China50 sites, 50 recruiting
- Recruiting
Beijing Ditan Hospital Capital Medical University
Beijing, 100015
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Peking University People's Hospital
Beijing, 100044
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Beijing Friendship Hospital
Beijing, 100050
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Beijing Youan Hospital, Capital Medical University
Beijing, 100069
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Beijing Tsinghua Changgung Hospital
Beijing, 102218
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Hospital of Jilin University
Changchun, 130021
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Hunan Provincial People's Hospital
Changsha, 410005
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Changzhou Third People's Hospital
Changzhou Shi, 214442
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
West China Hospital, Sichuan University
Chengdu, 610041
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Chongqing Three Gorges Central Hospital
Chongqing, 404000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First People's Hospital of Foshan
Foshan, 528000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Affiliated Hospital of Fujian Medical University
Fuzhou, 350005
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Guangzhou Eighth People's Hospital,Guangzhou Medical University
Guangzhou, 510000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Guangzhou First People's Hospital
Guangzhou, 510013
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
NanFang Hosptial
Guangzhou, 510515
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Affiliated Hospital, Zhejiang University
Hangzhou, 310003
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Zhejiang Hospital
Hangzhou, 310013
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Affiliated Hospital of Hangzhou Normal University
Hangzhou, 310015
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine
Hangzhou, 310016
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Hospital of Jiaxing
Jiaxing, 314001
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
First People's Hospital of Yunnan Province
Kunming, 650032
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Liaocheng People's Hospital
Liaocheng, 252000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, 471003
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, 330006
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Second Affiliated Hospital to Nanchang University
Nanchang, 330006
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Second Hospital of Nanjing
Nanjing, 210003
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Nanjing Drum Tower Hospital
Nanjing, 210008
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Nanjing Jiangning Hospital
Nanjing, 211100
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Ningbo Second Hospital
Ningbo, 315010
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
General Hospital of Ningxia Medical University
Ningxia, 750004
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Pingxiang People's Hospital
Pingxiang, 337000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Qingdao Municipal Hospital
Qingdao, 266001
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, 200025
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Huashan Hospital, Fudan University
Shanghai, 200040
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Shanghai General Hospital
Shanghai, 200080
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Shanghai East Hospital
Shanghai, 200120
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Renji Hospital Shanghai Jiaotong University School of Medicine
Shanghai, 200127
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Shanghai Public Health Clinical Center
Shanghai, 201508
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Renmin Hospital of Wuhan University
Shanghai, 430060
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Sixth People's Hospital of Shenyang
Shenyang, 110006
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Third People's Hospital of Shenzhen
Shenzhen, 518112
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Fifth People's Hospital of Suzhou
Suzhou, 215007
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Tianjin Third Central Hospital
Tianjin, 300170
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Tianjin Second People's Hospital
Tianjin, 300192
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, 325000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, 430022
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Second Affiliated Hospital of medical college of Xi'an JiaoTong University
Xi'an, 710004
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
First Affiliated Hospital of Xi'an JiaoTong University
Xi'an, 710061
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
Sixth People's Hospital of Zhengzhou
Zhengzhou, 450005
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
- Recruiting
The Third People's Hospital of Zhenjiang
Zhenjiang, 212021
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
United Kingdom21 sites, 21 recruiting
- Recruiting
Aberdeen Royal Infirmary
Aberdeen, AB25 2ZN
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Velocity Clinical Research, Bristol
Bristol, BS82RA
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Frimley Park Hospital
Camberley, GU16 7UJ
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Derby City General Hospital
Derby, DE22 3NE
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Queen Elizabeth Hospital Birmingham
Edgbaston, Birmingham, B15 2WB
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Royal Devon and Exeter Hospital, Wonford
Exeter, EX2 5AX
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Panthera Biopartners - Glasgow
Glasgow, G51 4TY
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Hull Royal Infirmary
Hull, HU3 2JZ
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Aintree University Hospital
Liverpool, L9 7Al
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Royal Free Hospital
London, NW32PF
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
King's College Hospital
London, SE5 9RS
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Chelsea and Westminster Hospital
London, SW10 9NH
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Newcastle General Hospital
Newcastle upon Tyne, NE4 6BE
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Accellacare North London
Northwood, HA6 2RN
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Accellacare - South London
Orpington, London, BR5 3QG
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Panthera Biopartners - Preston
Preston, PR2 9RB
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Panthera Biopartners - Rochdale
Rochdale, OL11 4AU
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Panthera Biopartners - Sheffield
Sheffield, S2 5FX
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Southampton General Hospital
Southampton, SO16 6YD
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
St George's Hospital
Tooting, London, SW17 0QT
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
- Recruiting
Panthera Biopartners - York
York, YO24 4LJ
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Germany15 sites, 15 recruiting
- Recruiting
Charité - Universitätsmedizin Berlin
Berlin, 13353
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH
Bochum, 44892
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Köln (AöR)
Cologne, 50937
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Technische Universität Dresden
Dresden, 01307
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Frankfurt
Frankfurt, 69590
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Heidelberg
Heidelberg, 69120
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universität des Saarlandes
Homburg, 66421
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Klinikum Landshut AdöR der Stadt Landshut
Landshut, 84034
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Lübeck, 23538
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Otto-von-Guericke-Universität Magdeburg
Magdeburg, 39120
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Heidelberg
Mannheim, 68167
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Münster
Münster, 49129
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
St. Josefs-Hospital Wiesbaden
Wiesbaden, 65189
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
- Recruiting
Universitätsklinikum Würzburg AÖR
Würzburg, 97080
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
France14 sites, 14 recruiting
- Not yet recruiting
CHU Amiens-Picardie
Amiens, 80054
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Centre Hospitalier Universitaire D'Angers
Angers, 49100
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Recruiting
Hopital Beaujon
Clichy, 92110
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Hopital Henri Mondor
Créteil, 94000
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Recruiting
HOP Dijon-Bourgogne
Dijon, 21000
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Centre Hospitalier De Versailles
Le Chesnay, 78150
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Hôpital Claude Huriez
Lille, 59000
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Recruiting
Hopital De La Croix-Rousse
Lyon, 69004
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Hôpital de l'Archet
Nice, 06200
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Hopitaux Universitaires Pitié-Salpétrière
Paris, 75013
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Hôpital Cochin
Paris, 75014
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Centre Hospitalier Universitaire De Bordeaux
Pessac, 33600
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
- Not yet recruiting
Hôpital Rangueil - CHU de Toulouse
Toulouse, 31059
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
India12 sites, 12 recruiting
- Recruiting
Aryav Superspeciality Hospital
Ahemdabad, 380060
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Post Graduate Institute of Medical Education and Research
Chandigarh, 14209-1120
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Osmania Medical College & Hospital
Hyderabad, Afzalgunj, 500012
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
SR Kalla Memorial Hospital
Jaipur, 302001
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Atharva Multispecialty Hospital and research Centre
Lucknow, 226003
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Midas Multispeciality Hospital Pvt. Ltd.
Nagpur, 440010
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Insitute of Liver and Billiary Sciences
New Delhi, 110 070
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
Rohtak, 124001
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Yashoda Hospitals - Secunderabad
Secunderabad, 500003
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Surat Institute of Digestive Sciences
Surat, 395002
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
BAPS Pramukh Swami Hospital
Surat, 395009
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
- Recruiting
Gujarat Gastro and Vascular Hospital
Surat, 395009
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
South Korea10 sites, 10 recruiting
- Recruiting
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, 14584
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Pusan National University Hospital
Busan, 49241
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Inha University Hospital
Incheon, 22332
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Seoul National University Hospital
Seoul, 03080
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Asan Medical Center
Seoul, 05505
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
SMG-SNU Boramae Medical Center
Seoul, 07061
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Korea University Guro Hospital
Seoul, 08308
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Samsung Medical Center
Seoul, 6351
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Chung-Ang University Hospital
Seoul, 6973
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
- Recruiting
Yonsei University Wonju Severance Christian Hospital
Wŏnju, 26426
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Taiwan10 sites, 10 recruiting
- Recruiting
Changhua Christian Hospital
Changhua, 50006
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsuing City, 80756
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Chung Shan Medical University Hospital
Taichung, 40201
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Taichung Veterans General Hospital
Taichung, 40705
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
National Cheng Kung University Hospital
Tainan, 70403
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Chi Mei Medical Center
Tainan, 71004
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
National Taiwan University Hospital
Taipei, 10048
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Taipei Medical University Hospital
Taipei, 110301
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Taipei Veterans General Hospital
Taipei, 112201
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
- Recruiting
Chang Gung Medical Foundation (CGMF) - Linkou Bran
Taoyuan, 33305
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Argentina9 sites, 9 recruiting
- Recruiting
CIPREC
Buenos Aires, 1061
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
IDIM - Instituto de Diagnostico e Investigaciones Metabolicas
Buenos Aires, C1012AAR
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
Centro de Investigaciones Metabolicas (CINME)
Buenos Aires, C1056ABJ
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
Buenos Aires Macula S.A.
Buenos Aires, C1061AAE
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
Glenny Corp - Centro Medico Saavedra
Buenos Aires, C1430CKE
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
Hospital General de Agudos Dr. J. M. Ramos Mejia
Ciudad Autonoma Buenos Aires, C1221ADC
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
Hospital Universitario Austral
Pilar, B1629ODT
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
DIM Clinica Privada
Ramos Mejía, 1704
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
- Recruiting
Hospital El Cruce
San Juan Bautista, B1888
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Brazil9 sites, 9 recruiting
- Not yet recruiting
Universidade Federal do Rio de Janeiro
Barra, 21941-617
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Hospital Universitário João de Barros Barreto
Belém, 66073-005
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Not yet recruiting
Hospital das Clinicas da Universidade Federal de Minas Gerais (HC-UFMG)
Belo Horizonte, 30130-100
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Universidade Estadual Paulista "Julio De Mesquita Filho"
Botucatu, 18618-970
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Hospital das Clinicas da Faculdade de Medicina da USP
Cerqueira César, 05403-000
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Hospitalar Moinhos de Vento
Porto Alegre, 90035-001
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Universidade Federal do Rio Grande do Sul
Porto Alegre, 90035-903
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Hospital de Base
São José do Rio Preto, 15090-000
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
- Recruiting
Rocco E Nazato Servicos Medicos LTDA
São Paulo, 04077-020
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Italy9 sites, 9 recruiting
- Recruiting
Policlinico S. Orsola-Malpighi
Bologna, 40138
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Az.Osp. Universitaria "Ospedali Riuniti"
Foggia, 71122
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico
Milan, 20122
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Università di Modena e Reggio Emilia
Modena, 41121
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Palermo, 90127
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Fondazione Policlinico Universitario Campus Bio-medico
Rome, 00128
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Istituto Clinico Humanitas
Rozzano, 20089
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
- Recruiting
Universita Degli Studi di Torino
Torino, 10126
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Poland9 sites, 9 recruiting
- Recruiting
Medical Centre FutureMeds Krakow
Krakow, 31-501
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
Santa SP. z o.o
Lodz, 90-302
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
FutureMeds Lodz
Lodz, 91-363
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie
Lublin, 20-081
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
ID Clinic
Mysłowice, 41-400
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
FutureMeds Warszawa Centrum
Warsaw, 00-215
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
Bodyclinic sp. z o.o. sp.k.
Warsaw, 03-712
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
FutureMeds Wroclaw
Wroclaw, 53-673
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
- Recruiting
EMC Instytut Medyczny S.A. - Wroclaw
Wroclaw, 54-144
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Spain9 sites, 9 recruiting
- Recruiting
Complejo Hospitalario Universitario A Coruña
A Coruña, 15006
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Universitari Vall d'Hebron
Barcelona, 08035
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Clínic de Barcelona
Barcelona, 08036
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Universitario Reina Sofía
Córdoba, 14004
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Universitario 12 de Octubre
Madrid, 28041
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Universitario La Paz
Madrid, 28046
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Puerta de Hierro
Majadahonda, 28222
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, 36071
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
- Recruiting
Hospital Clínico de Santiago
Santiago de Compostela, 15706
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Australia8 sites, 7 recruiting
- Recruiting
Monash Health
Clayton, Victoria, 3168
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
- Completed
Concord Repatriation General Hospital
Concord, New South Wales, 2139
- Recruiting
Austin Health
Heidelberg, Victoria, 3084
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
- Recruiting
Nepean Hospital
Kingswood, New South Wales, 2747
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
- Recruiting
Liverpool Hospital
Liverpool, New South Wales, 2170
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
- Recruiting
Royal Melbourne Hospital
Parkville, Victoria, 3050
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
- Recruiting
Royal Perth Hospital
Perth, Western Australia, 6000
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
- Recruiting
Westmead Hospital
Westmead, New South Wales, 2145
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Mexico8 sites, 8 recruiting
- Recruiting
Centro de Investigacion Clinica del Pacifico (CICPA)
Acapulco de Juárez, 39670
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Centro de Investigación y Gastroenterología
Col. Xoco, 03339
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Instituto de Diabetes, Obesidad y Nutrición S.C.
Cuernavaca, 62250
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Medical Care and Research
Mérida, 97070
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Clinicos Asociados BOCM SC
Mexico City, 03300
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Centro de Investigación y Gastroenterología
Mexico City, 06700
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Practice Dr Rosa Isela Luna Ceballos
Veracruz, 91910
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
- Recruiting
Centro de Alta Especialidad del Estado de Veracruz
Xalapa, 91020
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Turkey (Türkiye)8 sites, 8 recruiting
- Recruiting
Hacettepe Universitesi Tip Fakultesi
Ankara, 06230
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Gazi Universitesi Tip Fakultesi
Ankara, 06560
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Uludag Universitesi Tip Fakultesi
Bursa, 16059
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi
Fatih, 34093
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Koc Universitesi Hastanesi
Istanbul, 34010
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Memorial Bahçelievler Hospital
Istanbul, 34180
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Ege Universitesi Tip Fakultesi
Izmir, 35030
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
- Recruiting
Recep Tayyip Erdogan Universitesi Egitim ve Arastirma Hastanesi
Rize, 53020
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Bulgaria7 sites, 7 recruiting
- Recruiting
MHAT Sv. Ivan Rilski EOOD
Gorna Oryahovitsa, 5100
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
- Recruiting
Multi-profile Hospital For Active Treatment-Uni Hospital Ltd.
Panagyurishte, 4500
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
- Recruiting
Acibadem City Clinic Tokuda University Hospital EAD
Sofia, 1407
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
- Recruiting
Diagnostic Consultative Center Alexandrovska
Sofia, 1431
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
- Recruiting
University Multiprofile Hospital for Active Treatment St. Ivan Rilski EAD
Sofia, 1431
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
- Recruiting
Medical Military Academy MHAT Sofia
Sofia, 1606
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
- Recruiting
Medical Center New Rehabilitation Center EOOD
Stara Zagora, 6001
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
Canada6 sites, 6 recruiting
- Recruiting
Viable Clinical Research
Bridgewater, Nova Scotia, B4N 3N2
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
- Recruiting
University of Calgary
Calgary, Alberta, T2N 4N1
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
- Recruiting
McGill University Health Centre (MUHC)
Montreal, Quebec, H3H 2R9
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
- Recruiting
Diex Recherche Québec
Québec, G1V 4T3
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
- Recruiting
Toronto Liver Centre
Toronto, Ontario, M6H 3M1
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
- Recruiting
University of British Columbia
Vancouver, British Columbia, V5Z 1M9
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
Austria5 sites, 5 recruiting
- Recruiting
Medical University of Graz
Graz, 8036
Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com
- Recruiting
Ordensklinikum Linz GmbH
Linz, 4010
Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com
- Recruiting
Medical University of Vienna
Vienna, 1090
Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com
- Recruiting
Klinik Hietzing
Vienna, 1130
Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com
- Recruiting
Klinikum Wels - Grieskirchen GmbH
Wels, 4600
Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com
Belgium4 sites, 4 recruiting
- Recruiting
Hopital Erasme
Brussels, 1070
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
- Recruiting
Universitair Ziekenhuis Antwerpen
Edegem, 2650
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
- Recruiting
Ziekenhuis Oost-Limburg
Genk, 3600
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
- Recruiting
Centre Hospitalier Universitaire de Liège
Liège, 4000
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
Hungary4 sites, 4 recruiting
- Recruiting
Dr. Rethy Pal Hospital
Békéscsaba, 5600
Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com
- Recruiting
Obudai Egeszegugyi Centrum
Budapest, 1036
Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com
- Recruiting
Semmelweis Egyetem Sebeszeti, Transzplantacios es Gasztroenterologiai Klinika
Budapest, 1082
Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com
- Recruiting
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet
Budapest, 1097
Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com
Malaysia4 sites, 4 recruiting
- Recruiting
Hospital Ampang
Ampang, 68000
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
- Recruiting
Hospital Universiti Sains Malaysia
Kota Bharu, 16150
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
- Recruiting
University Malaya Medical Centre
Kuala Lumpur, 59100
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
- Recruiting
Queen Elizabeth Hospital
Putrajaya, 0000
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
New Zealand4 sites, 4 recruiting
- Recruiting
Christchurch Hospital
Christchurch, Canterbury, 8140
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
- Recruiting
New Zealand Clinical Research (NZCR)
Grafton, Auckland, 1010
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
- Recruiting
Waikato Hospital
Hamilton, Waikato Region, 3240
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
- Recruiting
Middlemore Hospital
Papatoetoe, Auckland, 2025
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
Chile3 sites, 3 recruiting
- Recruiting
Edificio Fleming
La Serena, 1710209
Boehringer Ingelheim, 800392345, chile@bitrialsupport.com
- Recruiting
Centro de Investigaciones Medicas UC
Santiago, 8330024
Boehringer Ingelheim, 800392345, chile@bitrialsupport.com
- Recruiting
Centro de Investigaciones Clinicas Viña del Mar
Viña del Mar, 2540488
Boehringer Ingelheim, 800392345, chile@bitrialsupport.com
Czechia3 sites, 3 recruiting
- Recruiting
Krajska nemocnice Liberec a.s.
Liberec, 460 01
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
- Recruiting
Research Site s.r.o.
Pilsen, 301 00
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
- Recruiting
Vseobecna Fakultni Nemocnice V Praze
Prague, 128 00
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
Netherlands3 sites, 3 recruiting
- Recruiting
Albert SchweitzerZiekenhuis
Dordrecht, 3318 AT
Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com
- Recruiting
Erasmus Medisch Centrum
Rotterdam, 3015 GD
Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com
- Recruiting
Franciscus Gasthuis
Schiedam, 3118 JH
Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com
Puerto Rico3 sites, 3 recruiting
- Recruiting
Klinical Investigations Group, LLC
San Juan, 00909
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
- Recruiting
Latin Clinical Trial Center
San Juan, 00909
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
- Recruiting
FDI Clinical Research
San Juan, 00927
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
Singapore3 sites, 3 recruiting
- Recruiting
National University Hospital
Singapore, 119074
Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com
- Recruiting
Singapore General Hospital
Singapore, 169608
Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com
- Recruiting
Changi General Hospital
Singapore, 529889
Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com
Switzerland3 sites, 3 recruiting
- Recruiting
Fondazione Epatocentro Ticino
Arzo, 6900
Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com
- Recruiting
Hopitaux Universitaires de Geneve (HUG)
Geneva, 1205
Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com
- Recruiting
University Hospital Zurich
Zurich, 8091
Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com
Georgia2 sites, 2 recruiting
- Recruiting
Ltd "Health"
Batumi, 6010
Boehringer Ingelheim, 800008086, sakartvelo@bitrialsupport.com
- Recruiting
Israeli - Georgian Medical Research Clinic Healthycore LTD
Tbilisi, 0112
Boehringer Ingelheim, 800008086, sakartvelo@bitrialsupport.com
Jordan2 sites, 2 recruiting
- Recruiting
The Speciality Hospital (TSH)
Amman, 11194
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
- Recruiting
Jordan University Hospital
Jordan, 13046
Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com
Kazakhstan2 sites, 2 recruiting
- Recruiting
Asfendiyarov Kazakh National Medical University
Almaty, 050000
Boehringer Ingelheim, 88000808264, kazakhstan@bitrialsupport.com
- Recruiting
Institute of Gastroenterology, Hepatology and Metabolism LLP
Almaty, 050026
Boehringer Ingelheim, 88000808264, kazakhstan@bitrialsupport.com
Romania2 sites, 2 recruiting
- Recruiting
Regional Institute of Gastroenterology Hepatology "Prof. Dr. O. Fodor"
Cluj-Napoca, 400162
Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com
- Not yet recruiting
Spital Judetean De Urgenta Satu Mare
Satu Mare, 440055
Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com
Saudi Arabia2 sites, 2 recruiting
- Recruiting
King Faisal Specialist Hospital and Research Center
Riyadh, 11564
Boehringer Ingelheim, 8001263002, saudi@bitrialsupport.com
- Recruiting
King Abdulaziz Medical City, National Guard Health Affairs
Riyadh, 14611
Boehringer Ingelheim, 8001263002, saudi@bitrialsupport.com
South Africa2 sites, 2 recruiting
- Recruiting
Practice Dr Naeem Moosa
Johannesburg, 1827
Boehringer Ingelheim, 0800988886, southafrica@bitrialsupport.com
- Recruiting
Inspired GI Care
Plumstead, 7800
Boehringer Ingelheim, 0800988886, southafrica@bitrialsupport.com
Hong Kong1 site, 1 recruiting
- Recruiting
Prince Of Wales Hospital
Hong Kong, 999077
Boehringer Ingelheim, 800965365, hongkong@bitrialsupport.com
About this study
Official title: A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis
This study is open to adults who are at least 18 years old and have:
- A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or
- A confirmed liver disease called metabolic-associated steatohepatitis (MASH)
- BMI of 27 kg/m2 or more or
- 25 kg/m2 or more if the participant is Asian.
Read more
People with a history of other chronic liver diseases or high alcohol intake cannot take part in this study. The purpose of this study is to find out whether a medicine called survodutide helps people with NASH or MASH improve their liver function.
Participants are put into 2 groups randomly, which means by chance. 1 group gets survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Each participant has twice the chance of getting survodutide. Participants and doctors do not know who is in which group. Participants inject survodutide or placebo under their skin once a week. All participants regularly receive counselling to make changes to their diet and to exercise regularly.
Participants are in the study for up to 4 and a half years. During this time, they visit the study site or have a remote visit by video call every 2, 4 or 6 weeks for about a 1 year and 5 months. After this time participants visit the trial site or have a remote visit every 3 months until the end of the study.
The doctors check participants' health and take note of any unwanted effects. The participants' body weight is regularly measured. At some visits the liver parameters are measured using different imaging methods. The participants also fill in questionnaires about their symptoms. The results are compared between the groups to see whether the treatment works.
- Being tested
- Survodutide, Placebo matching survodutide
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurvodutideCombination product
Also called BI 456906
Subcutaneous injection, pre-filled syringe
Placebo matching survodutideCombination product
Subcutaneous injection, pre-filled syringe
| Study group | Role | What they receive |
|---|---|---|
| Survodutide | Experimental | Not described Receives: Combination Product: Survodutide |
| Placebo | Placebo comparator | Not described Receives: Combination Product: Placebo matching survodutide |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to first occurrence of any component of the composite clinical endpoint (at EoS) consisting of: all-cause mortality, liver transplant, hepatic decompensation events, worsening of MELD score to ≥15 and progression to CSPH
MELD = model of end-stage liver disease CSPH = Clinically significant portal hypertension
Measured: up to 4.5 years.
Secondary outcomes (13)
Key secondary endpoint: Absolute change from baseline in enhanced liver fibrosis (ELF) score
Measured: At baseline and at Week 76.
Key secondary endpoint: Percentage change from baseline in body weight
Measured: At baseline and at Week 76.
Key secondary endpoint: Absolute change from baseline in glycosylated haemoglobin A1c (HbA1c) (%) in participants with type 2 diabetes mellitus (T2DM) at baseline
Measured: At baseline and at Week 76.
Key secondary endpoint: Absolute change from baseline in liver stiffness (kPa) in FibroScan® vibration-controlled transient elastography (VCTE)
Measured: At baseline and at Week 76.
Percentage change from baseline in liver stiffness in FibroScan® VCTE
Measured: At baseline and at Week 76.
Time to first occurrence of progression to CSPH
Measured: up to 4.5 years.
Time to first occurrence of any of the hepatic decompensation events (ascites, HE, or portal hypertension-related upper GI bleeding), or worsening of MELD score to ≥15
Measured: up to 4.5 years.
Occurrence of all-cause hospitalisation (first and recurrent)
Measured: up to 4.5 years.
Time to first occurrence of any of the adjudicated components of the composite endpoint 5-point major adverse cardiac event (5P-MACE)
Measured: up to 4.5 years.
Absolute changes from baseline in lipids (mg/dL)
Measured: At baseline and at Week 76.
Absolute change from baseline in aspartate aminotransferase (AST) (U/L)
Measured: At baseline and at Week 76.
Absolute change from baseline in alanine aminotransferase (ALT) (U/L)
Measured: At baseline and at Week 76.
Absolute change from baseline in liver stiffness (kPa) assessed by magnetic resonance elastography (MRE)
Measured: At baseline and at Week 76.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2024
- Study start12 Nov 2024
- Primary completion5 Jun 2029 (estimated)
- Study completion5 Jun 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic Dysfunction Associated SteatohepatitisStudies of the same condition, open and under way.
- More trials run by Boehringer IngelheimThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 1,590 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06632457
- Sponsor's protocol ID
- 1404-0064
- Other IDs
- 2024-513741-36-00, U1111-1307-0227
- Status last verified
- Oct 2026
- First submitted
- 8 Oct 2024
- Last updated
- 28 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Yes: Once the criteria in section 'time frame' are fulfilled, researchers can use the following link https:// www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis
- ClinicalTrials.gov ID
- NCT06632457
- Acronym / sponsor ID
- 1404-0064
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 1,590 participants (estimated)
- Lead sponsor
- Boehringer IngelheimIndustry (pharma, biotech, devices)
- Study start
- 12 Nov 2024 (actual)
- Primary completion
- 5 Jun 2029 (estimated)
- Study completion
- 5 Jun 2029 (estimated)
- First posted
- 9 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is open to adults who are at least 18 years old and have:
- A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or
- A confirmed liver disease called metabolic-associated steatohepatitis (MASH)
- BMI of 27 kg/m2 or more or
- 25 kg/m2 or more if the participant is Asian.
People with a history of other chronic liver diseases or high alcohol intake cannot take part in this study. The purpose of this study is to find out whether a medicine called survodutide helps people with NASH or MASH improve their liver function.
Participants are put into 2 groups randomly, which means by chance. 1 group gets survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Each participant has twice the chance of getting survodutide. Participants and doctors do not know who is in which group. Participants inject survodutide or placebo under their skin once a week. All participants regularly receive counselling to make changes to their diet and to exercise regularly.
Participants are in the study for up to 4 and a half years. During this time, they visit the study site or have a remote visit by video call every 2, 4 or 6 weeks for about a 1 year and 5 months. After this time participants visit the trial site or have a remote visit every 3 months until the end of the study.
The doctors check participants' health and take note of any unwanted effects. The participants' body weight is regularly measured. At some visits the liver parameters are measured using different imaging methods. The participants also fill in questionnaires about their symptoms. The results are compared between the groups to see whether the treatment works.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Survodutide | Experimental | Combination Product: Survodutide |
| Placebo | Placebo comparator | Combination Product: Placebo matching survodutide |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Male or female adults ≥18 years of age at the time of screening, and at least the legal age of consent in countries where it is >18 years
- Body mass index (BMI) ≥27 kg/m2(≥25 kg/m2 for Asian trial participants)
- Compensated metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.
- Magnetic resonance imaging proton density fat fraction (MRI-PDFF) fat fraction ≥5% or FibroScan® with controlled attenuation parameter (CAP) ≥288 dB/m, obtained during the screening period or a historic MRI-PDFF ≤12 weeks prior to randomisation (except for patients with 'cryptogenic cirrhosis' where MRI-PDFF <5% or FibroScan® with CAP <288 dB/m is allowed). This inclusion criterion does not apply for participants with a recent (≤12 months prior to randomisation) liver biopsy showing steatosis/steatohepatitis.
- Further inclusion criteria apply.
Key exclusion criteria (20 listed)
- Current or history (<5 years) of significant alcohol consumption, defined as an average of >140 g/week in female patients and >210 g/week in male patients, for a period of >3 consecutive months, or an inability to reliably quantify alcohol consumption based upon judgment of the investigator.
- Model of end-stage liver Disease (MELD) score >12 due to liver disease
- History or current (i.e. at screening) hepatic decompensation event of any of the following but not limited to:
- Any of the following lab test result at screening
- History or evidence of other chronic liver diseases, such as primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis or overlap syndrome, Wilson's disease, alpha-1-antitrypsin deficiency, or genetic haemochromatosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurvodutideAlso: BI 456906Subcutaneous injection, pre-filled syringe | Combination product | Survodutide |
| Placebo matching survodutideSubcutaneous injection, pre-filled syringe | Combination product | Placebo |
Primary outcome
Time to first occurrence of any component of the composite clinical endpoint (at EoS) consisting of: all-cause mortality, liver transplant, hepatic decompensation events, worsening of MELD score to ≥15 and progression to CSPH
Time frame: up to 4.5 years.
MELD = model of end-stage liver disease CSPH = Clinically significant portal hypertension
13 secondary outcomes
Key secondary endpoint: Absolute change from baseline in enhanced liver fibrosis (ELF) score
Time frame: At baseline and at Week 76.
Key secondary endpoint: Percentage change from baseline in body weight
Time frame: At baseline and at Week 76.
Key secondary endpoint: Absolute change from baseline in glycosylated haemoglobin A1c (HbA1c) (%) in participants with type 2 diabetes mellitus (T2DM) at baseline
Time frame: At baseline and at Week 76.
Key secondary endpoint: Absolute change from baseline in liver stiffness (kPa) in FibroScan® vibration-controlled transient elastography (VCTE)
Time frame: At baseline and at Week 76.
Percentage change from baseline in liver stiffness in FibroScan® VCTE
Time frame: At baseline and at Week 76.
Time to first occurrence of progression to CSPH
Time frame: up to 4.5 years.
Time to first occurrence of any of the hepatic decompensation events (ascites, HE, or portal hypertension-related upper GI bleeding), or worsening of MELD score to ≥15
Time frame: up to 4.5 years.
Occurrence of all-cause hospitalisation (first and recurrent)
Time frame: up to 4.5 years.
Time to first occurrence of any of the adjudicated components of the composite endpoint 5-point major adverse cardiac event (5P-MACE)
Time frame: up to 4.5 years.
Absolute changes from baseline in lipids (mg/dL)
Time frame: At baseline and at Week 76.
Absolute change from baseline in aspartate aminotransferase (AST) (U/L)
Time frame: At baseline and at Week 76.
Absolute change from baseline in alanine aminotransferase (ALT) (U/L)
Time frame: At baseline and at Week 76.
Absolute change from baseline in liver stiffness (kPa) assessed by magnetic resonance elastography (MRE)
Time frame: At baseline and at Week 76.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. Once the criteria in section 'time frame' are fulfilled, researchers can use the following link https:// www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.
Related trials for Metabolic Dysfunction Associated Steatohepatitis
Not yet recruiting
Efficacy of Carnitine Complex in Improving Hepatic Steatosis in Potential Liver Donors
Hepatic Steatosis, Fatty Liver
RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
RecruitingPhase 1
A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH
Metabolic Dysfunction-Associated Steatohepatitis
RecruitingPhase 3
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
RecruitingPhase 1
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Non-alcoholic Fatty Liver Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
447 sites in 37 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Survodutide in people with Metabolic Dysfunction Associated Steatohepatitis, run by Boehringer Ingelheim at 447 sites in 37 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 447 sites in United States, Japan, China, United Kingdom, Germany and 32 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Boehringer Ingelheim (1-800-243-0127, clintriage.rdg@boehringer-ingelheim.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to first occurrence of any component of the composite clinical endpoint (at EoS) consisting of: all-cause mortality, liver transplant, hepatic decompensation events, worsening of MELD score to ≥15 and progression to CSPH (time frame: up to 4.5 years.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.